| Current Price | $3.83 | Mkt Cap | $884.1M |
|---|---|---|---|
| Open | $3.71 | P/E Ratio | 0.00 |
| Prev. Close | $3.67 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.62 - $3.86 | Volume | 1,056,876 |
| 52-Wk Range | $1.82 - $6.09 | Avg. Daily Vol. | 2,797,995 |
| Current Price | $3.83 | Mkt Cap | $884.1M |
|---|---|---|---|
| Open | $3.71 | P/E Ratio | 0.00 |
| Prev. Close | $3.67 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.62 - $3.86 | Volume | 1,056,876 |
| 52-Wk Range | $1.82 - $6.09 | Avg. Daily Vol. | 2,797,995 |
The best Bull and Bear pitches based on recency and number of recommendations.
Was on my watch list at $3.50, but decided to go ahead and stick my toes in the water. In light, so will watch to see if I want to hold or add more.They are basically a women's healthcare company selling prescription and over the counter prenatal… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about TXMD.
Recs
steppenwolf2
(62.38)
Submitted: 3/24/2017 12:03:03 AM :
Start Price:
$6.62
NASDAQ:TXMD Score:
-70.43
This drug company's commitment to women's health will continue to drive growth, goodwill and brand loyalty for it's branded prescription, generic and OTC drugs. TXMD is a Buy with tremendous upside to a $24 target price in 12 months.
Recs
Costco21
(40.15)
Submitted: 12/7/2016 7:57:05 PM :
Start Price:
$6.56
NASDAQ:TXMD Score:
-75.49
cheap pipeline
Recs
mfgd
(76.66)
Submitted: 9/22/2016 12:25:29 PM :
Start Price:
$6.20
NASDAQ:TXMD Score:
-79.18
In company news (9-20), TherapeuticsMD ( TXMD) was lower this afternoon, giving back earlier gains Tuesday that followed the women's health care company late Monday saying federal regulators have accepted the new drug application for its Yuvvexy softgel treatment for painful sex in older women.
Acceptance of the application by the U.S. Food and Drug Administration starts the clock for the agency to make a final decision on market approval for the dyspareunia product candidate by May 7, 2017.
Better late than never. This is a long term pick.
Find the members with the highest scoring picks in TXMD.
glenn12345 (99.99) Score: +127.77
The Score Leader is the player with the highest score across all their picks in TXMD.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| whatisthepoint | 97.45 | 6/1/2016 |
|
5Y | $8.94 | -57.44% | +42.79% | +100.23 | 0 Comment | |
| Teacherman1 | 48.02 | 6/11/2019 |
|
3Y | $2.40 | +58.54% | +3.87% | +54.67 | 0 Comment | |
| GuruSLB | 93.46 | 6/20/2017 |
|
5Y | $5.51 | -30.94% | +23.05% | +53.99 | 0 Comment | |
| WildShaman | 96.68 | 7/5/2018 |
|
5Y | $6.35 | -40.08% | +10.15% | +50.23 | 0 Comment | |
| stainsolution | < 20 | 8/20/2019 |
|
5Y | $2.90 | +31.21% | +2.75% | +28.46 | 0 Comment | |
| glenn12345 | 99.99 | 12/20/2018 |
|
5Y | $3.64 | +4.53% | +20.62% | +16.09 | 0 Comment | |
| RayNobleEsq | 99.98 | 10/1/2019 |
|
5Y | $3.80 | +0.13% | +0.68% | +0.55 | 0 Comment | |
| TheSlightEdge | 98.93 | 10/8/2019 |
|
5Y | $3.55 | +7.18% | +3.02% | -4.16 | 0 Comment | |
| tbailey82 | < 20 | 11/12/2018 |
|
5Y | $4.91 | -22.51% | +8.15% | -30.66 | 0 Comment | |
| whatsthepoint | 99.98 | 9/5/2019 |
|
5Y | $2.81 | +35.41% | +0.57% | -34.84 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TrackJimCramer | 86.31 | 12/1/2016 |
|
3W | $5.90 | -35.51% | +36.54% | +72.04 | 0 Comment | |
| TrackJimCramer | 86.31 | 4/1/2015 |
|
3W | $6.37 | -7.38% | +6.74% | -14.12 | 12/1/2016 @ $5.90 | 0 Comment |
| TrackFBRCapitalM | 83.94 | 7/8/2014 |
|
NS | $5.25 | -27.52% | +52.06% | -79.59 | 0 Comment |
